These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23769292)

  • 21. Structural brain abnormalities correlate with clinical features in patients with drug-naïve OCD: A DARTEL-enhanced voxel-based morphometry study.
    Tang W; Huang X; Li B; Jiang X; Li F; Xu J; Yang Y; Gong Q
    Behav Brain Res; 2015 Nov; 294():72-80. PubMed ID: 26241173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The validation of the Hungarian version of the dimensional Yale-Brown obsessive-compulsive scale.
    Harsányi A; Csigó K; Rajkai C; Döme L; Demeter G; Racsmány M
    Ideggyogy Sz; 2012 Jan; 65(1-2):25-33. PubMed ID: 22338843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further psychometric properties of the Yale-Brown Obsessive Compulsive Scale - Second Edition.
    Wu MS; McGuire JF; Horng B; Storch EA
    Compr Psychiatry; 2016 Apr; 66():96-103. PubMed ID: 26995242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of an Individual-Level Approach to Identify Cortical Connectivity Biomarkers in Obsessive-Compulsive Disorder.
    Brennan BP; Wang D; Li M; Perriello C; Ren J; Elias JA; Van Kirk NP; Krompinger JW; Pope HG; Haber SN; Rauch SL; Baker JT; Liu H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):27-38. PubMed ID: 30262337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.
    Alonso P; Menchón JM; Mataix-Cols D; Pifarré J; Urretavizcaya M; Crespo JM; Jiménez S; Vallejo G; Vallejo J
    Psychiatry Res; 2004 Jul; 127(3):267-78. PubMed ID: 15296826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent class analysis of obsessive-compulsive symptoms in a clinical sample.
    Atli A; Boysan M; Çetinkaya N; Bulut M; Bez Y
    Compr Psychiatry; 2014 Apr; 55(3):604-12. PubMed ID: 24262128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of gray and white matter morphology in obsessive compulsive disorder.
    Gonçalves OF; Sousa S; Carvalho S; Leite J; Ganho A; Fernandes-Gonçalves A; Pocinho F; Carracedo A; Sampaio A
    Psicothema; 2017 Feb; 29(1):35-42. PubMed ID: 28126056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of nucleus accumbens volume in drug-naive, adult patients with obsessive-compulsive disorder.
    Narayanaswamy JC; Jose D; Kalmady S; Venkatasubramanian G; Reddy YC
    Aust N Z J Psychiatry; 2013 Oct; 47(10):930-7. PubMed ID: 23737599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corpus callosum abnormalities in medication-naïve adult patients with obsessive compulsive disorder.
    Jose D; Narayanaswamy JC; Agarwal SM; Kalmady SV; Venkatasubramanian G; Reddy YC
    Psychiatry Res; 2015 Mar; 231(3):341-5. PubMed ID: 25686521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study.
    Jenike MA; Breiter HC; Baer L; Kennedy DN; Savage CR; Olivares MJ; O'Sullivan RL; Shera DM; Rauch SL; Keuthen N; Rosen BR; Caviness VS; Filipek PA
    Arch Gen Psychiatry; 1996 Jul; 53(7):625-32. PubMed ID: 8660129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
    Szeszko PR; Ardekani BA; Ashtari M; Malhotra AK; Robinson DG; Bilder RM; Lim KO
    Arch Gen Psychiatry; 2005 Jul; 62(7):782-90. PubMed ID: 15997020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter structural alterations in pediatric obsessive-compulsive disorder: relation to symptom dimensions.
    Lázaro L; Ortiz AG; Calvo A; Ortiz AE; Moreno E; Morer A; Calvo R; Bargallo N
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():249-58. PubMed ID: 24977330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of brain volume changes in obsessive-compulsive disorder.
    Rotge JY; Guehl D; Dilharreguy B; Tignol J; Bioulac B; Allard M; Burbaud P; Aouizerate B
    Biol Psychiatry; 2009 Jan; 65(1):75-83. PubMed ID: 18718575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural correlates of symptom severity in obsessive-compulsive disorder using magnetization transfer and diffusion tensor imaging.
    Maleki S; Chye Y; Zhang X; Parkes L; Chamberlain SR; Fontenelle LF; Braganza L; Youssef G; Lorenzetti V; Harrison BJ; Yücel M; Suo C
    Psychiatry Res Neuroimaging; 2020 Apr; 298():111046. PubMed ID: 32106018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent validation of the dimensional Yale-Brown obsessive-compulsive scale (DY-BOCS).
    Pertusa A; Fernández de la Cruz L; Alonso P; Menchón JM; Mataix-Cols D
    Eur Psychiatry; 2012 Nov; 27(8):598-604. PubMed ID: 21570815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
    Hoexter MQ; Dougherty DD; Shavitt RG; D'Alcante CC; Duran FL; Lopes AC; Diniz JB; Batistuzzo MC; Evans KC; Bressan RA; Busatto GF; Miguel EC
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):569-80. PubMed ID: 22841131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced thickness of anterior cingulate cortex in obsessive-compulsive disorder.
    Kühn S; Kaufmann C; Simon D; Endrass T; Gallinat J; Kathmann N
    Cortex; 2013 Sep; 49(8):2178-85. PubMed ID: 23067727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural Correlates of Response to Pharmacotherapy in Obsessive-Compulsive Disorder: Individualized Cortical Morphology-Based Structural Covariance.
    Yun JY; Jang JH; Kim SN; Jung WH; Kwon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():126-33. PubMed ID: 26116795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Italian version of the Yale-Brown Obsessive Compulsive Scale-Second Edition (Y-BOCS-II) in a clinical sample.
    Melli G; Avallone E; Moulding R; Pinto A; Micheli E; Carraresi C
    Compr Psychiatry; 2015 Jul; 60():86-92. PubMed ID: 25842194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.